Nivolumab Enhances In Vitro Effector Functions of PD-1+ T-Lymphocytes and Leishmania-Infected Human Myeloid Cells in a Host Cell-Dependent Manner.
about
Nivolumab Enhances In Vitro Effector Functions of PD-1+ T-Lymphocytes and Leishmania-Infected Human Myeloid Cells in a Host Cell-Dependent Manner.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Nivolumab Enhances In Vitro Ef ...... a Host Cell-Dependent Manner.
@en
Nivolumab Enhances In Vitro Ef ...... a Host Cell-Dependent Manner.
@nl
type
label
Nivolumab Enhances In Vitro Ef ...... a Host Cell-Dependent Manner.
@en
Nivolumab Enhances In Vitro Ef ...... a Host Cell-Dependent Manner.
@nl
prefLabel
Nivolumab Enhances In Vitro Ef ...... a Host Cell-Dependent Manner.
@en
Nivolumab Enhances In Vitro Ef ...... a Host Cell-Dependent Manner.
@nl
P2093
P2860
P356
P1476
Nivolumab Enhances In Vitro Ef ...... a Host Cell-Dependent Manner.
@en
P2093
Christodoulos Filippis
Gabriele Reichmann
Gaetan Aime Noubissi Nzeteu
Ger van Zandbergen
Katharina Arens
Peter Crauwels
Zoe Waibler
P2860
P356
10.3389/FIMMU.2017.01880
P577
2017-12-22T00:00:00Z